Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Active Not Recruiting Phase 1 Trials for Diphenhydramine (DB01075)

Indication	Status	Phase
DBCOND0115568 (Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm)	Active Not Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04681105	Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies	Treatment	Acetaminophen (DB00316) Dexamethasone (DB01234) Diphenhydramine (DB01075) Flotetuzumab (DB15223) Ibuprofen (DB01050) Ranitidine (DB00863)